Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil

Journal of Clinical Periodontology

Volumn 32, Issue 3, 2005, Pages 294-298

  Miranda, Jaume ^a   Brunet, Lluís ^a   Roset, Pere ^b   Berini, Leonardo ^a   Farré, Magí ^b   Mendieta, Carlos ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Calcium channel blockers; Diltiazem; Gingival overgrowth; Risk factors; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; VERAPAMIL;

ADULT; AGED; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GINGIVA OVERGROWTH; GINGIVITIS; HUMAN; IATROGENIC DISEASE; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; PERIODONTICS; PERIODONTITIS; PREVALENCE; RISK FACTOR; STATISTICAL ANALYSIS; TOOTH PLAQUE;

AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; CROSS-SECTIONAL STUDIES; DENTAL PLAQUE INDEX; DILTIAZEM; FEMALE; GINGIVAL OVERGROWTH; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTAL POCKET; RISK FACTORS; VERAPAMIL;

EID: 16244419328     PISSN: 03036979     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2005.00662.x     Document Type: Article

References (37)

1. Akimoto, Y., Tanaka, S., Omata, H., Shibutani, J., Nakano, Y., Kaneko, K., Kawana, T., Teshigawara, H., Nakao, S. & Fujii, A. (1991) Gingival hyperplasia induced by nifedipine. Journal of Nihon University School of Dentisry 33, 174-181.
2. Angelopoulos, A. P. & Goaz, P. W. (1972) Incidence of diphenylhydantoin hyperplasia. Oral Surgery, Oral Medicine and Oral Pathology 34, 898-906.
3. Atilla, G. & Kütükçuler, N. (1998) Crevicular fluid interleukin-1β, tumor necrosis factor, and interleukin-6 levels in renal transplant patients receiving ciclosporine A. Journal of Periodontology 69, 784-790.
4. Bowman, J. M., Levy, B. A. & Grubb, R. V. (1988) Gingival overgrowth induced by diltiazem. Oral Surgery, Oral Medicine and Oral Pathology 65, 183-185.
5. Brown, R. S., Beaver, W. T. & Bootomley, W. K. (1991) On the mechanism of drug-induced gingival hyperplasia. Journal of Oral Pathology and Medicine 20, 201-209.
6. Brown, R. S., Sein, P., Corio, R. & Bottombley, W. K. (1990) Nitrendipine-induced gingival hyperplasia. Oral Surgery, Oral Medicine and Oral Pathology 70, 593-596.
7. Brunet, Ll., Miranda, J., Farré, M., Berini, L. & Mendieta, C. (1996) Gingival enlargement induced by drugs. Drug Safety 15, 219-231.
8. Brunet, Ll., Miranda, J., Roset, P., Berini, L., Farré, M. & Mendieta, C. (2001) Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. European Journal of Clinical Investigation 31, 781-788.
9. Bullón, P., Machuca, G., Martinez-Sahuquillo, A., Rios, J. V., Rojas, J. & Lacalle, J. R. (1994) Clinical assessment of gingival hyperplasia in patients treated with nifedipine. Journal of Clinical Periodontology 21, 256-259.
10. Bullón, P., Machuca, G., Martínez-Sahuquillo, A., Rios, J.V, Velasco, E., Rojas, J. & Lacalle, J. R. (1996) Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem. Journal of Periodontology 23, 649-657.
11. Bullón, P., Machuca, G., Martínez Sahuquillo, A., Rojas, J., Lacalle, J. R., Rios, J. V. & Velasco, E. (1995) Clinical assessment of gingival size among patients treated with diltiazem. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 79, 300-304.
12. Cebeci, I., Kantarci, A., Firatli, E., Çarin, M. & Tunzer, Ö. (1996) The effect of verapamil on the prevalence and severity of cyclosporine-induced gingival overgrowth in renal allograft recipients. Journal of Periodontology 67, 1201-1205.
13. Colvard, M. D., Bishop, J., Weissman, D. & Gargiulo, A. V. (1986) Cardizem-induced gingival hyperplasia. Periodontal Case Report 8, 67-68.
14. Cucchi, G., Giustiniani, S. & Robustelli, F. (1985) Gingival hyperplasia caused by verapamil. Italian Journal of Cardiology 15, 556-557.
15. Dukes, M. G. & Aronson, J. K. (2000) Myler's Side Effects of Drugs: An Encyclopedia of Adverse Reactions and Interactions, 40th edition. New York: Elsevier.
16. Ellis, J. S., Seymour, R. A., Steele, J. G., Robertson, P., Butler, T. J. & Thomason, J. M. (1999) Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. Journal of Periodontology 70, 63-67.
17. Fattore, L., Stablein, M., Bredfeldt, G., Semla, T., Moran, M. & Doherty-Greenberg, J. M. (1991) Gingival hyperplasia: a side effect of nifedipine and diltiazem. Special Care Dentistry 11, 107-109.
18. Giustiniani, S., Della Cuna, F. R. & Marieni, M. (1987) Hyperplastic gingivitis during diltiazem therapy. International Journal of Cardiology 15, 247-249.
19. Juncadella, E., Fandos, J. M., Alba, J. & Descarrega, R. (1994) Hiperplasia gingival inducida por amlodipino. Medicinia Clinica (Barcelona) 103, 358-359.
20. Lederman, D., Lummermann, M., Reuben, S. & Freedman, P. D. (1984) Gingival hyperplasia associated with nifedipine therapy. Oral Surgery 57, 620-622.
21. Löe, H. & Silness, J. (1963) Periodontal disease in pregnancy. I - Prevalence and severity. Acta Odontologica Scandinavica 21, 533-551.
22. Lombardi, T., Fiore-Donno, G., Belser, U. & DiFelice, R. (1991) Felodipine-induced gingival hyperplasia: a clinical and histoogic study. Journal of Oral Pathology and Medicine 20, 89-92.
23. Lucas, R. M., Howell, L. & Wall, B. (1985) Nifedipine-induced gingival hyperplasia: a histochemicall and ultrastructural study. Journal of Periodontology 56, 211-215.
24. Miller, C. S. & Damm, D. D. (1992) Incidence of verapamil-induced gingival hyperplasia in a dental population. Journal of Periodontology 63, 453-456.
25. Miranda, J., Brunet, Ll., Roset, P., Berini, L., Farré, M. & Mendieta, C. (2001) Prevalence and risk of gingival enlargement in patient treated with nifedipine. Journal of Periodontology 72, 605-611.
26. Nagano, S., Ogawa, T. & Fukuyama, S. (1985) Influence of nicardipine hydrochlorhide on hypotensive effect and insulin secretion in a patient of hypertensive diabetic mellitus. Japan Pharmacology and Therapeutics 19, 5309-5313.
27. Nery, E., Edson, R., Lee, K., Pruthi, V. & Watson, J. (1995) Prevalence of nifedipine-induced gingival hyperplasia. Journal of Periodontology 66, 572-578.
28. Pernu, H. E., Oikarinen, K., Hietanen, J. & Knuuttila, M. (1989) Verapamil-induced gingival overgrowth: a clinical, histologic and biochemical approach. Journal of Oral Pathology and Medicine 18, 422-425.
29. Quigley, G. A. & Hein, J. W. (1962) Comparative classifying efficiency of normal and power brushing. Journal of American Dental Association 65, 26-29.
30. Ramon, Y., Behar, S., Kishon, Y. & Engelberg, I. (1984) Gingival hyperplasia caused by nifedipine: a preliminary report. International Journal of Cardiology 5, 195-204.
31. Seymour, R. A. (1991) Calcium channel blockers and gingival overgrowth. British Dental Journal 170, 376-379.
32. Seymour, R. A., Ellis, J. S. & Thomason, J. M. (2000) Risk factors for drug-induced gingival overgrowth. Journal of Clinical Periodontology 27, 217-223.
33. Seymour, R. A., Ellis, J. S., Thomason, J. M., Monkman, S. & Idle, J. R. (1994) Amlodipine-induced gingival overgrowth. Journal of Clinical Periodontology 21, 281-283.
34. Seymour, R. A., Smith, D. G. & Turnbull, D. N. (1985) The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. Journal of Clinical Periodontology 12, 413-419.
35. Smith, M. & Glenert, U. (1987) Gingivhyperplasi forarsaget af behandling med verapamil. Tandlaegebladet 91, 849-850.
36. Sooriyamoorthy, M. & Gower, D. B. (1989) Drug induced gingival overgrowth: clinical features and possible mechanisms. Medical Science and Research 17, 881-884.
37. Steele, R. M., Schuna, A. A. & Schreiber, R. T. (1994) Calcium antagonist-induced gingival hyperplasia. Annals of Internal Medicine 120, 663-664.